FDA NDC Directory · JSON-LD · Markdown

Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate

NDC 57664-950 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerSun Pharmaceutical Industries, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215997
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsAMPHETAMINE ASPARTATE MONOHYDRATE (3.125 mg/1)
AMPHETAMINE SULFATE (3.125 mg/1)
DEXTROAMPHETAMINE SACCHARATE (3.125 mg/1)
DEXTROAMPHETAMINE SULFATE (3.125 mg/1)
Marketing started20240201
Package count1

External sources

Source: openFDA. Public-domain (CC0).